Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer-Reference-Cited by-同舟云学术

Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer

Published:2017-01 Issue:1 Volume:161 Page:116-126
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Venkatesh Shriya,Pasternak Jesse D.,Beninato Toni,Drake Frederick T.,Kluijfhout Wouter P.,Liu Chienying,Gosnell Jessica E.,Shen Wen T.,Clark Orlo H.,Duh Quan-Yang,Suh Insoo

Publisher

Elsevier BV

Subject

Surgery

Reference24 articles.

1. Increasing incidence of thyroid cancer in the United States, 1973-2002;Davies;JAMA,2006

2. The increasing incidence of small thyroid cancers: Where are the cases coming from?;Davies;Laryngoscope,2010

3. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer;Haugen;Thyroid,2016

4. An observational trial for papillary thyroid microcarcinoma in Japanese patients;Ito;World J Surg,2010

5. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation;Ito;Thyroid,2014

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of the ACR TIRADS Compared to the ATA 2015 Risk Stratification Systems in the Evaluation of Incidental Thyroid Nodules;Academic Radiology;2024-04

2. Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review;Endocrinology and Metabolism;2024-02-29

3. Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines;Endocrinology and Metabolism;2024-02-29

4. Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review;Endocrinology and Metabolism;2024-02-29

5. Active surveillance for adult low-risk papillary thyroid microcarcinoma—a review focused on the 30-year experience of Kuma Hospital—;Endocrine Journal;2024